EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A clinical study of ten-year prognosis in patients with lumbar disc herniation treated with condoliase in a phase III trial

Yukihiro Matsuyama, Tomohiro Banno, Hideaki Imabayashi, Tetsuro Takatsu, Fumihiro Oha, Takashi Tsuji, Tetsuya Watanabe, Masaki Tatsumura, Kyohei Sakaki, Yoji Ogura, Yoshihisa Suzuki, Tetsuya Ohara und 11 weitere

Journal of Orthopaedic Science · 2026

DOI: 10.1016/j.jos.2025.05.006 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Journal of Orthopaedic Science, 2026. Verfasst von Yukihiro Matsuyama und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan. Elect…. Hauptthemen laut MEDLINE: Intervertebral Disc Displacement, Lumbar Vertebrae, Intervertebral Disc Chemolysis. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seikagaku Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Condoliase is a chemonucleolytic agent approved in Japan for the treatment of lumbar disc herniation (LDH). There had been no follow-up evaluation of its long-term effects on discs covering a period exceeding 10 years. METHODS: The present study evaluated the 10-year post-dose outcomes of patients treated with condoliase during the phase III trial in terms of neurological results, Oswestry Disability Index (ODI), X-ray findings (disc height, posterior intervertebral angle, vertebral body translation), and magnetic resonance image findings (Modic classification, Pfirrmann grade). RESULTS: Among the 82 patients treated with condoliase during the phase III trial, 37 (45.1 %) were available for the 10-year post-dose follow-up in the present study. At 10 years post-dose, low back pain and leg pain were observed in 15 (40.5 %) and 6 (16.2 %) of 37 patients, and the number of patients with positive straight leg raise test, hypesthesia, muscle weakness, and deep tendon hyporeflexia were 1 (2.7 %), 2 (5.4 %), 0 (0 %), and 8 (21.6 %), respectively; mean ODI was 8.6, with 32/37 (86.5 %) patients having ODI of 0 %-20 %; 8 (21.6 %) patients had disc height decreased by ≥ 30 %; 1 patient had posterior intervertebral angle of ≥5° and 1 had vertebral body translation of ≥3 mm. Although 5 patients (13.5 %) underwent lumbar surgery after receiving condoliase, no patient underwent surgery for spinal instability. In the Modic classification, the number of patients with "Type 0," "Type 1," and "Type 3" decreased, while those with "Type 2" increased compared to evaluations conducted at 1-year post-dose. For Pfirrmann grade, the number of patients with "Grade IV" decreased and those with "Grade V″ increased from 1 to 10 years post-dose. CONCLUSIONS: No significant imaging findings necessitating surgery were observed, suggesting that chemonucleolysis with condoliase remains a safe and effective treatment option for LDH over the long term.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intervertebral Disc DisplacementLumbar VertebraeIntervertebral Disc ChemolysisHumansMaleFemaleMiddle AgedAdultPrognosisTreatment OutcomeFollow-Up StudiesDisability EvaluationMagnetic Resonance ImagingTime FactorsJapanPain Measurement

Stichwörter der Autor:innen

10 yearChemonucleolysisCondoliaseFollow-up studyLumbar disc herniation

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan. Electronic address: spine-yu@hama-med.ac.jp.
  • Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan.
  • Department of Orthopaedic Surgery, Saiseikai Central Hospital, 1-4-17 Mita, Minato-ku, Tokyo, 108-0073, Japan.
  • Department of Orthopaedic Surgery, Gifu Prefectural Tajimi Hospital, 5-161 Maebatacho, Tajimi, Gifu, 507-8522, Japan.
  • Department of Orthopaedic Surgery, Hakodate Central General Hospital, 33-2 Honcho, Hakodate, Hokkaido, 040-8585, Japan.
  • Department of Orthopaedic Surgery, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Förderung

  • Seikagaku Corporation

Zitieren

APA

Matsuyama, Y., Banno, T., Imabayashi, H., Takatsu, T., Oha, F., Tsuji, T., Watanabe, T., Tatsumura, M., Sakaki, K., Ogura, Y., Suzuki, Y., Ohara, T., Komatsubara, T., Hyakumachi, T., Hoshino, M., Sakuma, Y., Chino, K., Ando, K., Yamada, K., …, & Chiba, K. (2026). A clinical study of ten-year prognosis in patients with lumbar disc herniation treated with condoliase in a phase III trial. Journal of Orthopaedic Science. https://doi.org/10.1016/j.jos.2025.05.006

Vancouver

Matsuyama Y, Banno T, Imabayashi H, Takatsu T, Oha F, Tsuji T, et al. A clinical study of ten-year prognosis in patients with lumbar disc herniation treated with condoliase in a phase III trial. Journal of Orthopaedic Science. 2026. doi:10.1016/j.jos.2025.05.006

BibTeX
@article{Matsuyama2026,
  author = {Matsuyama, Yukihiro and Banno, Tomohiro and Imabayashi, Hideaki and Takatsu, Tetsuro and Oha, Fumihiro and Tsuji, Takashi and Watanabe, Tetsuya and Tatsumura, Masaki and Sakaki, Kyohei and Ogura, Yoji and Suzuki, Yoshihisa and Ohara, Tetsuya and Komatsubara, Tadashi and Hyakumachi, Takahiko and Hoshino, Masahiro and Sakuma, Yoshio and Chino, Kozo and Ando, Kei and Yamada, Kiyotaka and Watanabe, Ippei and Sato, Miwako and Shirogane, Taiichi and Chiba, Kazuhiro},
  title = {A clinical study of ten-year prognosis in patients with lumbar disc herniation treated with condoliase in a phase III trial},
  journal = {Journal of Orthopaedic Science},
  year = {2026},
  doi = {10.1016/j.jos.2025.05.006}
}
Kostenlos starten →